COMMUNIQUÉS West-GlobeNewswire

BiomX: Zorronet Completes Transition to New Advanced Data Center Supporting Business Expansion and Enhanced AI Capabilities
10/07/2026
NETANYA, Israel, July 10, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a company focused on defense, security, and critical infrastructure technologies, today announced that its [...]
Authority Magazine Features Kraig Biocraft Laboratories CEO Kim Thompson as an Industry Disruptor Reshaping the Future of Advanced Materials
10/07/2026
Interview Highlights Thompson's Entrepreneurial Vision and Kraig Labs' Mission to Bring Spider Silk to Commercial Scale ANN ARBOR, Mich., July 10, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB [...]
BioStem Technologies Publicly Files Form 10 Registration Statement with the Securities and Exchange Commission
10/07/2026
Advances progress towards planned Nasdaq uplisting POMPANO BEACH, Fla., July 10, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company [...]
VYNE Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Yarrow Bioscience
10/07/2026
Aggregate cash dividend of an estimated $16.5 million, or an estimated $0.38 per share NEW YORK, July 10, 2026 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that its [...]
Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer’s Biomarker Profiling
10/07/2026
Company to host scientific workshop featuring emerging eMTBR-Tau and BD-pTau217 research data for Alzheimer’s disease detection and staging FREMONT, Calif., July 10, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. ( [...]
BMGL Regains Compliance With Nasdaq Minimum Bid Price Requirement
10/07/2026
Singapore, July 10, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”) today announced that it has received notification from Nasdaq that the Company has regained compliance with the Nasdaq [...]
No easy answers: European research consortia take on major challenges
10/07/2026
COPENHAGEN, Denmark, July 10, 2026 (GLOBE NEWSWIRE) -- Nine new Challenge Programme grants from the Novo Nordisk Foundation will support ambitious research across fungal diseases, cardiometabolic disease, soil health [...]
UREVO Wins Red Dot Award 2026 for AI-Powered Wireless Recovery Boots
10/07/2026
ESSEN, Germany, July 10, 2026 (GLOBE NEWSWIRE) -- Smart wellness innovator UREVO has won the Red Dot Award: Product Design 2026 in the Innovative Design category for its AI-Powered Wireless Recovery Boots . The honor [...]
MindRank Announces $52 Million Series B Financing
10/07/2026
Funding to advance MindRank’s AI-native drug R&D engine and innovative pipeline, including MDR-001, an oral small-molecule GLP-1 receptor agonist in Phase III clinical development in China HANGZHOU, China, July 09, [...]
Avance Clinical to Showcase Asia and China Growth Strategy at BIO Asia–Taiwan 2026
10/07/2026
Global CRO highlights multi-regional trial delivery, early-phase Australia advantages, and expanding support for biotech sponsors across Asia and China ADELAIDE, Australia, July 10, 2026 (GLOBE NEWSWIRE) -- Avance [...]
Avance Clinical to Showcase Asia and China Growth Strategy at BIO Asia–Taiwan 2026
10/07/2026
Global CRO highlights multi-regional trial delivery, early-phase Australia advantages, and expanding support for biotech sponsors across Asia and China ADELAIDE, Australia, July 10, 2026 (GLOBE NEWSWIRE) -- Avance [...]
Ryoncil® Delivers Net Revenue of US$36M for the Fourth Quarter Ended 30 June 2026
10/07/2026
Continued Growth Underpins First Full Year Net Revenue of US$115M NEW YORK, July 09, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory [...]
Cue Biopharma Announces $50.0 Million Private Placement
10/07/2026
BOSTON, July 09, 2026 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical stage biopharmaceutical company focused on developing transformative therapies targeting functional cures for immunological [...]
Clover Health to Report Second Quarter 2026 Financial Results on August 5, 2026
09/07/2026
WILMINGTON, Del., July 09, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its financial results after the [...]
Denali Therapeutics to Give Opening Plenary Address at Alzheimer’s Association International Conference (AAIC) 2026 and Highlight Breakthroughs in Delivering Biologic Therapies Across Blood-Brain Barrier
09/07/2026
Denali co-founder and CEO Ryan Watts, Ph.D., to deliver opening plenary address at 2026 AAIC in London on July 12, 2026 Presentation will highlight recent scientific advances and future opportunities to accelerate [...]
Option Care Health to Announce Second Quarter 2026 Financial Results and Host Conference Call
09/07/2026
BANNOCKBURN, Ill., July 09, 2026 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced [...]
Adaptive Biotechnologies to Report Second Quarter 2026 Financial Results on July 29, 2026
09/07/2026
SEATTLE, July 09, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical [...]
Inventiva annonce la finalisation de la restructuration des BSA BEI à la suite de l'émission des Nouveaux BSA BEI
09/07/2026
Daix (France), New York City (New York, États-Unis), le 9 juillet, 2026 – Inventiva (Euronext Paris et NASDAQ : IVA ) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement d'une [...]
Foundation for Sarcoidosis Research Announces New Partnership with Patient Advocate Foundation to Expand Insurance and Disability Support for Sarcoidosis Patients
09/07/2026
CHICAGO, July 09, 2026 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR), the leading international organization dedicated to finding a cure for sarcoidosis and improving care for those living with the [...]

Pages